In the BioHarmony Drug Report Database

"Preview" Icon

Doxepin

Doxepin, Silenor, Sinequan, Zonalon (doxepin) is a small molecule pharmaceutical. Doxepin was first approved as Doxepin on 1982-01-01. It is used to treat anxiety disorders, atopic dermatitis, depressive disorder, pain, and pruritus amongst others in the USA. The pharmaceutical is active against sodium-dependent serotonin transporter and sodium-dependent noradrenaline transporter. In addition, it is known to target histamine H1 receptor. Doxepin hydrochloride’s patents are valid until 2030-09-07 (FDA).

 

Trade Name

 

Doxepin, Silenor, Sinequan, Zonalon
 

Common Name

 

doxepin
 

ChEMBL ID

 

CHEMBL1628227
 

Indication

 

anxiety disorders, atopic dermatitis, depressive disorder, pain, pruritus, psychotic affective disorders
 

Drug Class

 

Tricyclic compounds

Image (chem structure or protein)

Doxepin structure rendering